Category Archives: Daily interesting IP news

Fosamprenavir – opposition – india

Indian patent journal of this week (Sep 16th, 2011) has a post grant opposition filed under section 25(2). Lupin has filed post grant opposition to 240930 (2210/Cal/1998) under section 25(2)  on June 08, 2011. The ‘930 patent seems to cover Fosamprenavir, is … Continue reading

Posted in Daily interesting IP news, Patent case | Tagged , , , , , , | Leave a comment

Azilsartan medoxomil – opposition – India

Indian patent journal (of September 9th 2011) has some new post grant oppositions filed under section 25(2) of Patent Act 1970. The controller may generally publish such post oppositions filed under section 25(2)in official journal. Ranbaxy, Lupin and MSN have filed post grant opposition … Continue reading

Posted in Daily interesting IP news, Ranbaxy | Tagged , , , , , | 4 Comments

Imatinib India News aggregation

[Business Line] [SC Order] [Money control] In a latest order by SC India, the Novartis imatinib case will be listed “before a Bench of one where Hon’ble Mr. Justice Dalveer Bhandari is not a member“.

Posted in Daily interesting IP news | Tagged , , | Leave a comment

Gilead – HIV Treatment – Indian companies

[businesswire] Gilead Sciences, Inc. announced today an expansion of its global access program in an effort to provide accelerated access to Gilead medicines for the treatment of HIV/AIDS. The changes announced today include new licensing terms with four India-based drug … Continue reading

Posted in Daily interesting IP news | Tagged , , , , , | Leave a comment

India: New-Post Grant Oppositions-Published

1) An opposition under Sec.25(2) has been filed by M/s. Cipla Limited, Mumbai, India on 18th April, 2011 in respect of Patent No.242347 (1702/KOLNP/2006) in the name of M/s. Meda Pharma GmbH & Co, KG, Germany – Combination of R, R- … Continue reading

Posted in Daily interesting IP news, Patent case | Tagged , , , , | Leave a comment

Utility Models India

[Published Disucssion Paper] [DIPP] DIPP has initiated a new discussion paper on introduction of Utility model legal frame work in India. This discussion paper is eight one from the serious of discussion papers published by DIPP on policy reforms. This paper … Continue reading

Posted in Daily interesting IP news | Tagged , , | Leave a comment

Brazil INPI makes Examiner reports online

INPI announced that PTO has digitalized the orders of examiners. This system, at present, restricted only to recent journal publications (Publication no: 2014 & 2013). This system, called e-Patentes/Parecer, contains 655 reports of examiners and 117 prior art documents cited … Continue reading

Posted in Daily interesting IP news | Leave a comment

India: Compulsory License

Today BS publishes an article on Compulsory license in india. I think this article misses/wrongly mentions a drug name Maraviroc for which Natco applied CL. Natco applied CL for both Maraviroc and Sorafenib. [DNA India] [ET] Domestic drug makers set … Continue reading

Posted in Daily interesting IP news | Tagged | Leave a comment

Eprotirome: Karo Bio and Alkem collaborate

[Pharmabiz] Karo and Alkem collaborate to develop Eprotirome. Karo bio has granted license to Alkem to commercialize in India and certail countires. Alkem will participate in Karo Bio’s phase III programme for eprotirome by conducting a pivotal clinical study on … Continue reading

Posted in Daily interesting IP news | Tagged , , | Leave a comment

Genzyme Hyaluaronic acid products

In addition to earlier post, Genzyme filed another complaint against Seikagaku and Anika Therapeutics on infringement of 7,931,030 (expires on 20/12/2025). [Seikagaku] [Anika Therapeutics] Genzyme markets Synvisc and Synvisc One. Both are injectable elastic and viscous cross-linked HA gel approved in US.  Seikagaku received … Continue reading

Posted in Daily interesting IP news, Patent case | Tagged , , , | Leave a comment